CVS Health has appointed a health care executive as its next chief strategy officer.
The company named Violetta Ostafin executive VP and chief strategy officer, effective July 11. She will succeed Josh Flum, also the head of CVH Health Ventures, who is leaving the company after 18 years at the end of June.
Prior to joining CVS Health, Ostafin served as global chief operating officer, health solutions at Aon, plc and CEO of Aon’s Latin America health solutions business. Ostafin was also a managing director and partner at Boston Consulting Group. Shas deep experience across the health care continuum, including a particular focus on business model evolution, introducing consumer-driven solutions and operational effectiveness.
“Violetta’s deep health care experience has been focused on bold innovation and finding new sources of growth, two priorities for CVS Health,” said CVS Health president and CEO Karen S. Lynch. “Her accomplishments are driven by a passion for improving how consumers experience health care, which aligns with our goals and values.”
Ostafin will become a member of CVS Health’s executive leadership team and report to Lynch. She will lead strategy development across the core businesses and identify new market opportunities and product innovations that accelerate growth and further the company’s vision.
On his LinkedIn page, Flum wrote that he is “off to my next adventure.”
“Very excited for some time off and then back to using all of the skills I have developed over the years to have an even greater impact on health care innovation going forward,” he said.